Indian Ovarian Cancer Study Links Germline Mutations to Diverse Survival Outcomes
A study of Indian ovarian cancer patients reveals that germline genetic variants and surgical timing significantly influence progression and survival ...
A study of Indian ovarian cancer patients reveals that germline genetic variants and surgical timing significantly influence progression and survival ...
A qualitative study reveals that female BRCA1/2 carriers view polygenic risk scores and multi-cancer early detection tests as supplemental context ...
Clinicians in Colombia report a rare case of multilocus inherited neoplasia alleles syndrome involving novel concurrent BRCA1 and BRCA2 pathogenic ...
A prospective observational study found automated breast ultrasound achieved high patient acceptance and improving acquisition efficiency among women in an ...
A review proposes that PARP1 dynamically interprets DNA lesion geometry and chromatin context rather than operating as a uniform damage ...
Saturation genome editing across human haploid and mammary epithelial cells resolves mechanisms of variant pathogenicity and refines breast cancer risk ...
A literature review evaluates how next-generation sequencing informs diagnosis, targeted therapy, and disease monitoring in ovarian cancer while outlining clinical ...
Results from the randomized phase II ZZ-FIRST academic clinical trial show that biomarker guidance is necessary to maximize clinical benefit ...
A study of Brazilian triple-negative breast cancer patients found improved progression-free survival in carriers of BRCA1 and HRR variants alongside ...
Preclinical and clinical investigations reveal that the transcription factor TFAP2A enhances radiotherapy resistance in non-small cell lung cancer by directly ...
Researchers have identified a prehistoric BRCA1 founder variant in Rwandan breast cancer cases that originated thousands of years ago.
Healthy women carrying pathogenic BRCA1 or BRCA2 variants have significantly fewer hypomethylated, presumably active ribosomal DNA copies in their blood ...
A retrospective single-center study of 148 patients found that two-thirds of women with germline BRCA-mutated breast cancer underwent risk-reducing salpingo-oophorectomy, ...
A study of 77 patients found matrix-producing metaplastic carcinoma of the breast is marked by frequent germline HRD gene variants, ...
New research shows that removing the chromatin remodeler ALC1 sensitizes a broad range of ovarian cancer models to PARP inhibitors ...
A retrospective Japanese cohort study associated expanded insurance coverage for BRCA testing with a median testing interval of 54 days ...
A cross-sectional study found that 36.16% of at-risk relatives underwent family-specific genetic testing, with uptake independently associated with education, family ...
A study of 58 patients found that ovarian cancer ascites-derived cell blocks supported immunohistochemical diagnosis and detected homologous recombination repair ...
Network analysis and B16F0 cell experiments linked carboplatin with CDKN1A, BRCA1, PTEN and AKT1 in melanoma, without establishing clinical benefit.
A study of 1,009 Chinese breast cancer patients found that BRCA1 mutation carriers had far higher rates of complete tumor ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.